Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zifan Meng, Qing Liu, Yanfei Liu, Yuanming Yang, Changfeng Shao & Shaoqiang Zhang. (2023) Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells. Journal of Chemotherapy 35:7, pages 653-661.
Read now
Read now
Marion Bossennec, Anthony Di Roio, Christophe Caux & Christine Ménétrier-Caux. (2018) MDR1 in immunity: friend or foe?. OncoImmunology 7:12.
Read now
Read now
Yu-Long Lan, Zhen-Long Yu, Jia-Cheng Lou, Xiao-Chi Ma & Bo Zhang. (2018) Update on the effects of the sodium pump α1 subunit on human glioblastoma: from the laboratory to the clinic. Expert Opinion on Investigational Drugs 27:9, pages 753-763.
Read now
Read now
Articles from other publishers (99)
Wenjuan Zhang, Ju-Hee Oh, Wenqiu Zhang, Sneha Rathi, Jiayan Le, Surabhi Talele, Jann N. Sarkaria & William F. Elmquist. (2023) How Much is Enough? Impact of Efflux Transporters on Drug delivery Leading to Efficacy in the Treatment of Brain Tumors. Pharmaceutical Research.
Crossref
Crossref
Meenakshi Tiwari, Lokendra Kumar Sharma & Ajit Kumar Saxena. 2023. Glioblastoma - Current Evidence. Glioblastoma - Current Evidence.
William D. Gwynne, Yujin Suk, Stefan Custers, Nicholas Mikolajewicz, Jeremy K. Chan, Zsolt Zador, Shawn C. Chafe, Kui Zhai, Laura Escudero, Cunjie Zhang, Olga Zaslaver, Chirayu Chokshi, Muhammad Vaseem Shaikh, David Bakhshinyan, Ian Burns, Iqra Chaudhry, Omri Nachmani, Daniel Mobilio, William T. Maich, Patricia Mero, Kevin R. Brown, Andrew T. Quaile, Chitra Venugopal, Jason Moffat, J. Rafael Montenegro-Burke & Sheila K. Singh. (2022) Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma. Cancer Cell 40:12, pages 1488-1502.e7.
Crossref
Crossref
Aleksandra Majchrzak-Celińska, Arvinder Sidhu, Izabela Miechowicz, Witold Nowak & Anna-Maria Barciszewska. (2022) ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors. Journal of Clinical Medicine 11:19, pages 5655.
Crossref
Crossref
Shweta Bisht, Manisha Nigam, Shyam S. Kunjwal, Plygun Sergey, Abhay Prakash Mishra & Javad Sharifi-Rad. (2022) Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. Stem Cells International 2022, pages 1-28.
Crossref
Crossref
David Bakhshinyan, Ashley A. AdileJeff LiuWilliam D. Gwynne, Yujin SukStefan CustersIan Burns, Mohini Singh, Nicole McFarlaneMinomi K. SubapandithaMaleeha A. Qazi, Parvez VoraMichelle M. Kameda-Smith, Neil SavageKim L. Desmond, Nazanin TatariDamian Tran, Mathieu Seyfrid, Kristin Hope, Nicholas A. Bock, Chitra VenugopalGary D. Bader & Sheila K. Singh. (2021) Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence. Science Advances 7:50.
Crossref
Crossref
Dan Liu, Jing Ke, Yang Liu, Huiling Rao, Zhiming Tang, Ying Liu, Zhaoyang Zhang, Lei You, Xiangyin Luo, Zequn Sun, Zhijun He, Fei Li, Zhengpeng Qiu, Junjie Hu, Magdaleena Naemi Mbadhi, Junming Tang, Fuyun Wu & Shan Li. (2021) The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance. Molecular Carcinogenesis 60:12, pages 813-825.
Crossref
Crossref
Mahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, Oronzo Brunetti, Nicola Silvestris & Behzad Baradaran. (2021) The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Mina Park, Jee Won Hwang, Yena Cho, Saegun Kim, Sang Hoon Han, Jinsuh Yu, Sojung Ha, Woo-Young Kim, Su-Nam Kim, In Su Kim & Yong Kee Kim. (2021) A novel synthetic microtubule inhibitor exerts antiproliferative effects in multidrug resistant cancer cells and cancer stem cells. Scientific Reports 11:1.
Crossref
Crossref
Yagmur Muftuoglu & Frank Pajonk. (2021) Targeting Glioma Stem Cells. Neurosurgery Clinics of North America 32:2, pages 283-289.
Crossref
Crossref
Ana Laura V. Alves, Izabela N. F. Gomes, Adriana C. Carloni, Marcela N. Rosa, Luciane S. da Silva, Adriane F. Evangelista, Rui Manuel Reis & Viviane Aline O. Silva. (2021) Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Christophe Olivier, Lisa Oliver, Lisenn Lalier & François M. Vallette. (2021) Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Vanessa Castelli, Antonio Giordano, Elisabetta Benedetti, Francesco Giansanti, Massimiliano Quintiliani, Annamaria Cimini & Michele d’Angelo. (2021) The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death. Cancers 13:2, pages 328.
Crossref
Crossref
Sabra K. Salim, Neil Savage, William T. Maich, Chitra Venugopal & Sheila K. Singh. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
185
199
.
Mohammed Ahmed, Maite Verreault, Xavier Declèves & Ahmed Idbaih. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
243
261
.
Arata Tomiyama. 2021. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies
547
585
.
M. Asif, M. Usman, Shahid Ayub, Sahar Farhat, Zilli Huma, Jawad Ahmed, Mohammad A. Kamal, Deema Hussein, Aneela Javed & Ishaq Khan. (2020) Role of ATP-Binding Cassette Transporter Proteins in CNS Tumors: Resistance- Based Perspectives and Clinical Updates. Current Pharmaceutical Design 26:37, pages 4747-4763.
Crossref
Crossref
David S Kim. (2020) Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy. Future Oncology 16:28, pages 2251-2264.
Crossref
Crossref
R. Gajendra Reddy, Unis Ahmad Bhat, Sumana Chakravarty & Arvind Kumar. (2020) Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells. Cancer Chemotherapy and Pharmacology 86:2, pages 165-179.
Crossref
Crossref
Ignazio de Trizio, Mariella Errede, Antonio d'Amati, Francesco Girolamo & Daniela Virgintino. (2020) Expression of P-gp in Glioblastoma: What we can Learn from Brain Development. Current Pharmaceutical Design 26:13, pages 1428-1437.
Crossref
Crossref
Semo Jun, Seok Won Kim, Byeol Kim, In-Youb Chang & Seon-Joo Park. (2020)
Oncogenic Ras downregulates
mdr1b
expression through generation of reactive oxygen species
. The Korean Journal of Physiology & Pharmacology 24:3, pages 267-276.
Crossref
Crossref
Mahfuz Al Mamun, Kaiissar Mannoor, Jun Cao, Firdausi Qadri & Xiaoyuan Song. (2020) SOX2 in cancer stemness: tumor malignancy and therapeutic potentials. Journal of Molecular Cell Biology 12:2, pages 85-98.
Crossref
Crossref
Iris Chiara Salaroglio, Carmen Abate, Barbara Rolando, Luigi Battaglia, Elena Gazzano, Elena Colombino, Costanzo Costamagna, Laura Annovazzi, Marta Mellai, Francesco Berardi, Maria Teresa Capucchio, Davide Schiffer & Chiara Riganti. (2019) Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain–Blood Barrier and Glioblastoma Stem Cells. Molecular Pharmaceutics 16:8, pages 3361-3373.
Crossref
Crossref
J. W. Ivey, E. M. Wasson, N. Alinezhadbalalami, A. Kanitkar, W. Debinski, Z. Sheng, R. V. Davalos & S. S. Verbridge. (2019) Characterization of Ablation Thresholds for 3D-Cultured Patient-Derived Glioma Stem Cells in Response to High-Frequency Irreversible Electroporation. Research 2019.
Crossref
Crossref
Charlotte Aaberg-Jessen, Louise Fogh, Mia Dahl Sørensen, Bo Halle, Nils Brünner & Bjarne Winther Kristensen. (2017) Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines. Pathology & Oncology Research 25:1, pages 59-69.
Crossref
Crossref
Tian‐Huei Chu, Hoi‐Hung Chan, Tsung‐Hui Hu, E‐Ming Wang, Yi‐Ling Ma, Shih‐Chung Huang, Jian‐Ching Wu, Yi‐Chen Chang, Wen‐Tsan Weng, Zhi‐Hong Wen, Deng‐Chyang Wu, Yi‐Ming Arthur Chen & Ming‐Hong Tai. (2018) Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats. Cancer Medicine 7:6, pages 2567-2580.
Crossref
Crossref
Raghupathy Vengoji, Muzafar A. Macha, Surinder K. Batra & Nicole A. Shonka. (2018) Natural products: a hope for glioblastoma patients. Oncotarget 9:31, pages 22194-22219.
Crossref
Crossref
Austin Y Shull & Christopher L Farrell. (2018) ‘Et tu, inhibitor?’: the potential for HIV inhibitors to prime P-gp-mediated chemoresistance in cancer. Future Science OA 4:2, pages FSO269.
Crossref
Crossref
Mrinmay Kumar Mallik. (2018) An attempt to understand glioma stem cell biology through centrality analysis of a protein interaction network. Journal of Theoretical Biology 438, pages 78-91.
Crossref
Crossref
Kushal Kandhari, Hina Agraval, Arpana Sharma, Umesh C. S. Yadav & Rana P. Singh. 2018. Functional Food and Human Health. Functional Food and Human Health
587
622
.
Juwina Wijaya, Yu Fukuda & John Schuetz. (2017) Obstacles to Brain Tumor Therapy: Key ABC Transporters. International Journal of Molecular Sciences 18:12, pages 2544.
Crossref
Crossref
Krystal D. Nolan, Jasmine Kaur & Jennifer S. Isaacs. (2016) Secreted heat shock protein 90 promotes prostate cancer stem cell heterogeneity. Oncotarget 8:12, pages 19323-19341.
Crossref
Crossref
Ssu-Yin Yen, Hong-Meng Chuang, Mao-Hsuan Huang, Shinn-Zong Lin, Tzyy-Wen Chiou & Horng-Jyh Harn. (2017) n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma. International Journal of Molecular Sciences 18:2, pages 372.
Crossref
Crossref
Ewelina Piktel, Katarzyna Niemirowicz, Marzena Wątek, Tomasz Wollny, Piotr Deptuła & Robert Bucki. (2016) Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy. Journal of Nanobiotechnology 14:1.
Crossref
Crossref
Yoshitaka Murota, Kouichi Tabu & Tetsuya Taga. (2016) Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes. BMC Cancer 16:1.
Crossref
Crossref
In-geun Ryoo, Geon Kim, Bo-hyun Choi, Sang-hwan Lee & Mi-Kyoung Kwak. (2016) Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres. Biomolecules & Therapeutics 24:5, pages 482-488.
Crossref
Crossref
Shigeo Nohara, Kazunori Kato, Daisuke Fujiwara, Naoya Sakuragi, Kazuyoshi Yanagihara, Yoshimi Iwanuma & Yoshiaki Kajiyama. (2016) Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer. Clinics and Research in Hepatology and Gastroenterology 40:4, pages 494-503.
Crossref
Crossref
Rajendar K. Mittapalli, Alexander H. Chung, Karen E. Parrish, Donna Crabtree, Kyle G. Halvorson, Guo Hu, William F. Elmquist & Oren J. Becher. (2016) ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B–Driven Brainstem Glioma Model. Molecular Cancer Therapeutics 15:5, pages 819-829.
Crossref
Crossref
Ting-Gang Fu, Ling Wang, Wei Li, Jian-Zhong Li & Jian Li. (2016) miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma. International Journal of Molecular Medicine.
Crossref
Crossref
G Xi, E Hayes, R Lewis, S Ichi, B Mania-Farnell, K Shim, T Takao, E Allender, C S Mayanil & T Tomita. (2015) CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro. Oncogene 35:2, pages 241-250.
Crossref
Crossref
Axel Schulenburg, Katharina Blatt, Sabine Cerny-Reiterer, Irina Sadovnik, Harald Herrmann, Brigitte Marian, Thomas W Grunt, Christoph C Zielinski & Peter Valent. (2015) Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?. Journal of Hematology & Oncology 8:1.
Crossref
Crossref
Wenyi Gu, Indira Prasadam, Meihua Yu, Fengxia Zhang, Patrick Ling, Yin Xiao & Chengzhong Yu. (2015) Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway. BMC Cancer 15:1.
Crossref
Crossref
Mrinmay Chakrabarti & Swapan K. Ray. (2015) Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells. Brain Research 1629, pages 85-93.
Crossref
Crossref
Yunpeng Cui, Feng Yang & Lu He. (2015) Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells. Molecular Medicine Reports.
Crossref
Crossref
Rajarshi Sengupta, Amy Barone, Jayne Marasa, Sara Taylor, Erin Jackson, Nicole M. Warrington, Shyam Rao, Albert H. Kim, Jeffrey R. Leonard, David Piwnica-Worms & Joshua B. Rubin. (2015) Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget 6:21, pages 18282-18292.
Crossref
Crossref
Mi-Ra Lee, Sun-Young Ji, Khalilullah Mia-Jan & Mee-Yon Cho. (2015) Chemoresistance of CD133 + colon cancer may be related with increased survivin expression. Biochemical and Biophysical Research Communications 463:3, pages 229-234.
Crossref
Crossref
David Bakhshinyan, Maleeha A. Qazi, Neha Garg, Chitra Venugopal, Nicole McFarlane & Sheila K. Singh. 2015. Principles of Stem Cell Biology and Cancer. Principles of Stem Cell Biology and Cancer
145
167
.
Pojul Loying, Janvie Manhas, Sudip Sen & Biplab Bose. (2015) Autoregulation and Heterogeneity in Expression of Human Cripto-1. PLOS ONE 10:2, pages e0116748.
Crossref
Crossref
Breno S. Salgado, Suely Nonogaki, Luisa M. Soares, Angela Akamatsu, Cristiano R. N. da Silva, Thiago P. Anacleto, Rodolfo Malagó, Rafael M. Rocha, Fátima Gärtner & Noeme S. Rocha. (2015) Expression of Multidrug Resistance ATP-Binding Cassette (ABC) Transporters in Canine Mammary Tumors. Advances in Breast Cancer Research 04:03, pages 77-85.
Crossref
Crossref
Yong Zhang, Shao-Xiang Wang, Ji-Wei Ma, Hai-Ying Li, Jie-Cheng Ye, Si-Ming Xie, Bin Du & Xue-Yun Zhong. (2014) EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition. Journal of Neuro-Oncology 121:1, pages 41-52.
Crossref
Crossref
Margaret L. Thomas, Krysta M. Coyle, Mohammad Sultan & Paola Marcato. 2015. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
477
518
.
Luca Persano, Alessandro Della Puppa, Elena Porcù, Francesca Maule & Giampietro Viola. 2015. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
273
296
.
Imad Saeed Khan & Moneeb Ehtesham. 2015. Stem Cell Biology in Neoplasms of the Central Nervous System. Stem Cell Biology in Neoplasms of the Central Nervous System
167
187
.
Wenyi Gu, Nigel McMillan & Chengzhong Yu. 2015. Cervical Cancer. Cervical Cancer
173
182
.
Imad Saeed Khan & Moneeb Ehtesham. (2014) Targeting glioblastoma cancer stem cells: the next great hope?. Neurosurgical Focus 37:6, pages E7.
Crossref
Crossref
Pengfei Jiang, Rajesh Mukthavavam, Ying Chao, Ila Sri Bharati, Valentina Fogal, Sandra Pastorino, Xiuli Cong, Natsuko Nomura, Matt Gallagher, Taher Abbasi, Shireen Vali, Sandeep C Pingle, Milan Makale & Santosh Kesari. (2014) Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. Journal of Translational Medicine 12:1.
Crossref
Crossref
David Díaz-CarballoSebastian GustmannHolger JastrowAli Haydar AcikelliPhilip DammannJacqueline KleinUlrike DembinskiWalter BardenheuerSascha MalakMarcos J. Araúzo-BravoBeate SchultheisConstanze AldingerDirk Strumberg. (2014) Atypical Cell Populations Associated with Acquired Resistance to Cytostatics and Cancer Stem Cell Features: The Role of Mitochondria in Nuclear Encapsulation. DNA and Cell Biology 33:11, pages 749-774.
Crossref
Crossref
Daniela Chirio, Marina Gallarate, Elena Peira, Luigi Battaglia, Elisabetta Muntoni, Chiara Riganti, Elena Biasibetti, Maria Teresa Capucchio, Alberto Valazza, Pierpaolo Panciani, Michele Lanotte, Laura Annovazzi, Valentina Caldera, Marta Mellai, Gaetano Filice, Silvia Corona & Davide Schiffer. (2014) Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. European Journal of Pharmaceutics and Biopharmaceutics 88:3, pages 746-758.
Crossref
Crossref
Ana R. Rama, Pablo J. Alvarez, Roberto Madeddu & Antonia Aranega. (2014) ABC transporters as differentiation markers in glioblastoma cells. Molecular Biology Reports 41:8, pages 4847-4851.
Crossref
Crossref
Lynnette Wei Hsien Koh, Tan Boon Toh, Carol Tang & Beng Ti Ang. 2014. Stem Cells and Cancer Stem Cells, Volume 11. Stem Cells and Cancer Stem Cells, Volume 11
75
91
.
S. Chockalingam & Siddhartha Sankar Ghosh. (2013) Amelioration of Cancer Stem Cells in Macrophage Colony Stimulating Factor-Expressing U87MG-Human Glioblastoma upon 5-Fluorouracil Therapy. PLoS ONE 8:12, pages e83877.
Crossref
Crossref
Naveen Kumar Vishvakarma, Anjani Kumar, Vivek Singh & Sukh Mahendra Singh. (2013) Hyperglycemia of tumor microenvironment modulates stage-dependent tumor progression and multidrug resistance: implication of cell survival regulatory molecules and altered glucose transport. Molecular Carcinogenesis 52:12, pages 932-945.
Crossref
Crossref
Fei Ye, Yibei Zhang, Yue Liu, Kazunari Yamada, Jonathan L. Tso, Jimmy C. Menjivar, Jane Y. Tian, William H. Yong, D?rthe Schaue, Paul S. Mischel, Timothy F. Cloughesy, Stanley F. Nelson, Linda M. Liau, William McBride & Cho-Lea Tso. (2013) Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence. PLoS ONE 8:11, pages e80397.
Crossref
Crossref
C. Riganti, I. C. Salaroglio, V. Caldera, I. Campia, J. Kopecka, M. Mellai, L. Annovazzi, A. Bosia, D. Ghigo & D. Schiffer. (2013) Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway. Neuro-Oncology 15:11, pages 1502-1517.
Crossref
Crossref
Louqiang Zhang, Yichao Xia, Longjiang Li, Yin Wang, Ying Liu, Chunjie Li & Tao Yu. (2013) Cancer Stem Cell-Like Cells Exist in Mucoepidermoid Carcinoma Cell Line MC3. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 20:12, pages 589-600.
Crossref
Crossref
Jiang-jie DuanWen QiuSen-lin XuBin WangXian-zong YeYi-fang PingXia ZhangXiu-wu BianShi-cang Yu. (2013) Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done. Stem Cells and Development 22:16, pages 2221-2239.
Crossref
Crossref
Michael D. Brooks, Rajarshi Sengupta, Steven C. Snyder & Joshua B. Rubin. (2013) Hitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche. Current Pathobiology Reports 1:2, pages 101-110.
Crossref
Crossref
Der-Yang Cho, Shinn-Zong Lin, Wen-Kuang Yang, Han-Chung Lee, Den-Mei Hsu, Hung-Lin Lin, Chun-Chung Chen, Chun-Lin Liu, Wen-Yuan Lee & Li-Hui Ho. (2013) Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme. Cell Transplantation 22:4, pages 731-739.
Crossref
Crossref
Ph. A. Koshkin, D. A. Chistiakov & V. P. Chekhonin. (2013) Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy. Biochemistry (Moscow) 78:4, pages 325-334.
Crossref
Crossref
Chih-Yu Peng, Pin-Chung Fong, Cheng-Chia Yu, Wan-Chi Tsai, Yew-Min Tzeng & Wen-Wei Chang. (2013) Methyl Antcinate A Suppresses the Population of Cancer Stem-Like Cells in MCF7 Human Breast Cancer Cell Line. Molecules 18:3, pages 2539-2548.
Crossref
Crossref
Mei Zhang & Jeffrey M. Rosen. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Sheila K SinghBranavan Manoranjan & Chitra Venugopal. (2013) Evolution of brain tumor-initiating cell research: in pursuit of a moving target. Future Neurology 8:1, pages 1-3.
Crossref
Crossref
Evan K. Noch & Kamel Khalili. 2013. AEG-1/MTDH/LYRIC Implicated in Multiple Human Cancers. AEG-1/MTDH/LYRIC Implicated in Multiple Human Cancers
159
192
.
Suzana A. Kahn, Ema Torrado, Dora Brites & Vivaldo Moura-Neto. 2013. Trends in Stem Cell Proliferation and Cancer Research. Trends in Stem Cell Proliferation and Cancer Research
435
462
.
Dania V?zquez-Blomquist, Julio Ra?l Fern?ndez, Jamilet Miranda, Claudia Bello, Jos? A. Silva, Regla C. Estrada, Lidia In?s Novoa, Daniel Palenzuela & Iraldo Bello. (2012) Selection of reference genes for use in quantitative reverse transcription PCR assays when using interferons in U87MG. Molecular Biology Reports 39:12, pages 11167-11175.
Crossref
Crossref
Dimitry A. Chistiakov & Vladimir P. Chekhonin. (2012) Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential. European Journal of Pharmacology 684:1-3, pages 8-18.
Crossref
Crossref
Shyam Rao, Rajarshi Sengupta, Eun Joo Choe, B. Mark Woerner, Erin Jackson, Tao Sun, Jeffrey Leonard, David Piwnica-Worms & Joshua B. Rubin. (2012) CXCL12 Mediates Trophic Interactions between Endothelial and Tumor Cells in Glioblastoma. PLoS ONE 7:3, pages e33005.
Crossref
Crossref
Chitra Venugopal, Na Li, Xin Wang, Branavan Manoranjan, Cynthia Hawkins, Thorsteinn Gunnarsson, Robert Hollenberg, Paula Klurfan, Naresh Murty, Jacek Kwiecien, Forough Farrokhyar, John P. Provias, Christopher Wynder & Sheila K. Singh. (2012) Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells. Stem Cell Research 8:2, pages 141-153.
Crossref
Crossref
Christina S Mullins, Sven Eisold, Ernst Klar & Michael Linnebacher. (2011) Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma. BMC Immunology 12:1.
Crossref
Crossref
Tooba A. Cheema, Ryuichi Kanai, Geon Woo Kim, Hiroaki Wakimoto, Brent Passer, Samuel D. Rabkin & Robert L. Martuza. (2011) Enhanced Antitumor Efficacy of Low-Dose Etoposide with Oncolytic Herpes Simplex Virus in Human Glioblastoma Stem Cell Xenografts. Clinical Cancer Research 17:23, pages 7383-7393.
Crossref
Crossref
W Gu, E Yeo, N McMillan & C Yu. (2011) Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer Gene Therapy 18:12, pages 897-905.
Crossref
Crossref
H. Sevim, J. F. Parkinson & K. L. McDonald. (2011) Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?. Journal of Cancer Research and Clinical Oncology 137:11, pages 1705-1712.
Crossref
Crossref
Kun Yang, Xin-Zu Chen, Bo Zhang, Chen Yang, Hai-Ning Chen, Zhi-Xin Chen, Zong-Guang Zhou, Jia-Ping Chen & Jian-Kun Hu. (2018) Is CD133 a Biomarker for Cancer Stem Cells of Colorectal Cancer and Brain Tumors? A Meta-Analysis. The International Journal of Biological Markers 26:3, pages 173-180.
Crossref
Crossref
Hye-Min Jeon, Young-Woo Sohn, Se-Young Oh, Sung-Hak Kim, Samuel Beck, Soonhag Kim & Hyunggee Kim. (2011) ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*–Mediated Suppression of SOX2. Cancer Research 71:9, pages 3410-3421.
Crossref
Crossref
Sagar Agarwal, Ramola Sane, Rajneet Oberoi, John R. Ohlfest & William F. Elmquist. (2011) Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Reviews in Molecular Medicine 13.
Crossref
Crossref
Sze Ue Luk, Wei Ney Yap, Yung‐Tuen Chiu, Davy TW Lee, Stephanie Ma, Terence Kin Wah Lee, Raja S Vasireddy, Yong‐Chuan Wong, Yick Pang Ching, Colleen Nelson, Yee Leng Yap & Ming‐Tat Ling. (2011) Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like population. International Journal of Cancer 128:9, pages 2182-2191.
Crossref
Crossref
Kazunari Yamada, Jonathan Tso, Fei Ye, Jinny Choe, Yue Liu, Linda M. Liau & Cho-Lea Tso. (2011) Essential Gene Pathways for Glioblastoma Stem Cells: Clinical Implications for Prevention of Tumor Recurrence. Cancers 3:2, pages 1975-1995.
Crossref
Crossref
Lin Cheng, Qiulian Wu, Zhi Huang, Olga A Guryanova, Qian Huang, Weinian Shou, Jeremy N Rich & Shideng Bao. (2011) L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. The EMBO Journal 30:5, pages 800-813.
Crossref
Crossref
Guido Frosina. (2011) Frontiers in targeting glioma stem cells. European Journal of Cancer 47:4, pages 496-507.
Crossref
Crossref
Kate W. R. Broadley, Martin K. Hunn, Kathryn J. Farrand, Kylie M. Price, Carole Grasso, Rose J. Miller, Ian F. Hermans & Melanie J. McConnell. (2011) Side Population is Not Necessary or Sufficient for a Cancer Stem Cell Phenotype in Glioblastoma Multiforme. Stem Cells 29:3, pages 452-461.
Crossref
Crossref
C?cile Thirant, Barbara Bessette, Pascale Varlet, St?phanie Puget, Josette Cadusseau, Silvina Dos Reis Tavares, Jeanne-Marie Studler, David Carlos Silvestre, Aur?lie Susini, Chiara Villa, Catherine Miquel, Alexandra Bogeas, Anne-Laure Surena, Am?lia Dias-Morais, Nadine L?onard, Fran?oise Pflumio, Ivan Bi?che, Fran?ois D. Boussin, Christian Sainte-Rose, Jacques Grill, Catherine Daumas-Duport, Herv? Chneiweiss & Marie-Pierre Junier. (2011) Clinical Relevance of Tumor Cells with Stem-Like Properties in Pediatric Brain Tumors. PLoS ONE 6:1, pages e16375.
Crossref
Crossref
Siu Tim Cheung, Phyllis F.Y. Cheung, Christine K.C. Cheng, Nicholas C.L. Wong & Sheung Tat Fan. (2011) Granulin-Epithelin Precursor and ATP-Dependent Binding Cassette (ABC)B5 Regulate Liver Cancer Cell Chemoresistance. Gastroenterology 140:1, pages 344-355.e2.
Crossref
Crossref
Marie-Pierre Junier & Ariane Sharif. (2011) Instabilité du phénotype cellulaire et cellules initiatrices des gliomes. Biologie Aujourd'hui 205:1, pages 63-74.
Crossref
Crossref
Alysha K. Croker & Alison L. Allan. 2011. Cancer Stem Cells in Solid Tumors. Cancer Stem Cells in Solid Tumors
403
429
.
Manuele Castelnuovo, Sara Massone, Roberta Tasso, Gloria Fiorino, Monica Gatti, Mauro Robello, Elena Gatta, Audrey Berger, Katharina Strub, Tullio Florio, Giorgio Dieci, Ranieri Cancedda & Aldo Pagano. (2010) An Alu‐like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. The FASEB Journal 24:10, pages 4033-4046.
Crossref
Crossref
Chao Chen, Beate Köberle, Andreas M. Kaufmann & Andreas E. Albers. (2010) A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment. Cancers 2:3, pages 1528-1554.
Crossref
Crossref
Franziska Hirschhaeuser, Heike Menne, Claudia Dittfeld, Jonathan West, Wolfgang Mueller-Klieser & Leoni A. Kunz-Schughart. (2010) Multicellular tumor spheroids: An underestimated tool is catching up again. Journal of Biotechnology 148:1, pages 3-15.
Crossref
Crossref
Roberta Riccioni, Maria Luisa Dupuis, Manuela Bernabei, Eleonora Petrucci, Luca Pasquini, Gualtieri Mariani, Maurizio Cianfriglia & Ugo Testa. (2010) The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells, Molecules, and Diseases 45:1, pages 86-92.
Crossref
Crossref
Sharada D. Vangipuram, Zhihong J. Wang & William D. Lyman. (2009) Resistance of stem‐like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents. Pediatric Blood & Cancer 54:3, pages 361-368.
Crossref
Crossref